Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Operational Update

8 Jul 2009 08:27

RNS Number : 3110V
Phorm Inc
08 July 2009
 



Phorm, Inc.

('Phorm' or the 'Company')

Operational update

Phorm (AIM: PHRM/PHRX), the personalisation technology company, makes the following clarificatory statement regarding its international progress and the UK market following recent press commentary.

International

Phorm has been focussing considerable effort on faster moving overseas opportunities to drive a first deployment of the Company's Webwise and Discover technology and to bring the Company to a revenue generating position. The Company continues to make excellent progress and is actively engaged in more than 15 markets worldwide including advanced negotiations with eight major ISPs of which three are engaged in trials.

Specifically, in Korea, live trials with KT, the leading Korean ISP remain on course with activities progressing in line with management expectations.

UK

In the UK, Phorm continues to hold a commercial agreement with BT. Following the trial of the Company's Webwise technology and the announcement of Phorm's consumer facing Webwise Discover product, BT plc ("BT") continues to believe that the interest-based advertising category offers major benefits for consumers and publishers alike. BT has confirmed to the Company that whilst it has no immediate plans to deploy and it is currently prioritising more pressing projects such as developing next generation broadband, it will monitor Phorm's progress with other internet service providers ("ISPs"). The Company is extremely encouraged by the fact that BT has stated that privacy was not a factor in their decision making. 

Virgin Media continues to believe interest-based advertising has potentially important benefits for consumers, ISPs and website owners. Given the fast moving nature of the sector, Virgin Media is extending its review of potential opportunities with suppliers including Phorm prior to making any commitment to launch any of these technologies

Unfortunately, on 7 July 2009, TalkTalk Telecom Ltd, a wholly owned subsidiary of the Carphone Warehouse Group PLC, terminated its agreement with Phorm. The Directors note that this relationship had not extended to any form of trial in contrast to BT and some international ISP's, as noted above.

Summary

Overall ISP discussions have been greatly accelerated by the launch of Webwise Discover and its clear benefit to consumers, which has been viewed as a key step forward by all of our partners, including those in the UK.  Phorm retains a strong balance sheet with adequate cash resources and the Directors remain very confident in Phorm's ability to deliver on the promise of this substantial opportunity.

  Enquiries: 

Phorm, Inc

Benjamin Usher

+44 20 7297 2521

Sarah Simon

+44 20 7297 2433

 

Citigate Dewe Rogerson

+44 20 7638 9571 

Justin Griffiths 

Simon Rigby

 

Canaccord Adams Limited

+44 20 7050 6500 

(Nominated Adviser)

Mark Williams

Andrew Chubb

About Phorm:

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in New York, Seoul, Moscow and London.

The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees.

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGGGNNRKGLZG
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.